Senesco Technologies Inc. is planning to merge with Fabrus Inc.

Senesco, headquartered in Bridgewater, N.J., is a clinical-stage biotechnology company that specializes in cancer therapeutics. The company is currently developing a product that is designed to treat certain types of cancer, including multiple myeloma, lymphocytic leukemia and non-Hodgkin’s B-cell lymphomas.  

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.